A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
CRISPR Therapeutics (CRSP) is back in focus after upsizing its convertible note offering to US$550 million, a key funding move tied directly to the company's gene editing ambitions and CASGEVY commercialization. See our latest analysis for CRISPR Therapeutics. CRISPR Therapeutics' share price has been volatile around recent earnings and the upsized convertible note deal, with a 7 day share price return of a 13.72% decline and a year to date share price return of a 9.34% decline. At the same time, the 1 year total shareholder return sits at 15.74%, highlighting mixed momentum as the market weighs funding dilution against gene editing progress and CASGEVY traction. If this financing story has you looking across the sector, it could be a good moment to scan 33 healthcare AI stocks as a starting list of other health tech names to research. With CRISPR Therapeutics trading at US$48.75 and an implied intrinsic discount of about 74%, along with a wide swing between recent losses and
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Prices Upsized Convertible Senior Notes OfferingGlobeNewswire
- CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 3/16/26 - Form 8-K
- 3/12/26 - Form 4
- 3/12/26 - Form 4
- CRSP's page on the SEC website